Stanley Hazen, MD, PhD, caused a stir last year. He went looking for heart disease in the stomach. And found it. In a landmark study published in Nature, Dr. Hazen and his team linked certain products of digestion, or “gut flora”, to the presence of coronary artery disease. They found that a gut flora product was even more powerful than cholesterol as a marker for coronary artery disease. This finding has thrown new light on the developed world’s leading cause of death, and is likely to inspire new approaches to diagnosis and treatment. Now Dr. Hazen is being honored with a Top 10 Clinical Research Achievement Award from the Clinical Research Forum. He is one of the first ever to receive this award from the organization, which is comprised of leading medical centers, professional groups and industrial partners.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Dr. Hazen is head of Preventive Cardiology at Cleveland Clinic, and a frequent contributor to TBE. Of his work on gut flora, he notes, “These studies are particularly exciting because they show an entirely new path for generating new classes of therapeutics for the treatment and prevention of heart disease.”
Hear an interview with Dr. Hazen – Heart disease and our inner ecology http://www.wksu.org/news/story/31337
Dr. Hazen is working with a company to develop a test based on this research http://www.cleveland.com/metro/index.ssf/2012/04/developing_a_cardiovascular_ri.html